BIs-(N-Tert-Butyl-3-Propanamide) Disulfane

Catalog No. :
ACRXOG117
CAS No. :
33311-96-5
Molecular Formula :
C14H28N2O2S2
Molecular Weight :
320.52

IUPAC Name:3,3'-disulfanediylbis(N-(tert-butyl)propanamide)

BIs-(N-Tert-Butyl-3-Propanamide) Disulfane structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg95%$335.00Login to see priceInquiryInquiry
250mg95%$437.00Login to see priceInquiryInquiry
1g95%$546.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameBIs-(N-Tert-Butyl-3-Propanamide) Disulfane
IUPAC Name3,3'-disulfanediylbis(N-(tert-butyl)propanamide)
MDL No.MFCD20921879
Molecular FormulaC14H28N2O2S2
Molecular Weight320.52
SMILESO=C(NC(C)(C)C)CCSSCCC(NC(C)(C)C)=O
InChI KeyFGHXJLYDXDNXDW-UHFFFAOYSA-N
SynonymBis-(N-Tert-Butyl-3-Propanamide) Disulfane;Bis-(N-Tert-Butyl-3-Propanamide) Disulfane(WXC03248);Bis-(N-Tert-Butyl-3-Propamide) Disulfane;Propanamide, 3,3'-dithiobis[N-(1,1-dimethylethyl)-;N-tert-Butyl-3-[[3-(tert-butylamino)-3-oxopropyl]disulfanyl]propanamide
CAS No.33311-96-5

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P280-P301+P312-P302+P352-P305+P351+P338

Synthetic Route by SureRoute

1. ACRXOG117 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACPLCQ651 route compound structure diagram
    ACPLCQ65160469-70-7
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACRXOG117 route product structure diagram
    ACRXOG11733311-96-5
Inquiry

2. ACRXOG117 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACPLCQ651 route compound structure diagram
    ACPLCQ65160469-70-7
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACRXOG117 route product structure diagram
    ACRXOG11733311-96-5
Inquiry

Comments (0)